ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE

ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE was reported 160919 times

These side effects are most commonly reported by patients taking ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE:

# Side effect Count
0 DRUG INEFFECTIVE 17470
1 FATIGUE 16835
2 HEADACHE 13723
3 PAIN 13406
4 NAUSEA 13374
5 OFF LABEL USE 12585
6 DIARRHOEA 11382
7 ARTHRALGIA 10474
8 DYSPNOEA 10278
9 VOMITING 7741
10 RASH 7651
11 PYREXIA 7646
12 DIZZINESS 7628
13 ASTHENIA 7530
14 PRURITUS 6844
15 PAIN IN EXTREMITY 6431
16 MALAISE 6292
17 BACK PAIN 6210
18 COUGH 5979
19 FALL 5917
20 PNEUMONIA 5883
21 DEATH 5799
22 NASOPHARYNGITIS 5785
23 PERIPHERAL SWELLING 5654
24 WEIGHT DECREASED 5636
25 WEIGHT INCREASED 5362
26 JOINT SWELLING 5255
27 INFUSION RELATED REACTION 4966
28 INSOMNIA 4965
29 ANXIETY 4661
30 BLOOD PRESSURE INCREASED 4648
31 CONSTIPATION 4647
32 RHEUMATOID ARTHRITIS 4627
33 SINUSITIS 4518
34 HYPERTENSION 4480
35 HYPERSENSITIVITY 4407
36 DECREASED APPETITE 4357
37 DRUG HYPERSENSITIVITY 4350
38 ABDOMINAL PAIN UPPER 4349
39 ABDOMINAL DISCOMFORT 4322
40 CONDITION AGGRAVATED 4304
41 EXPOSURE DURING PREGNANCY 4052
42 ABDOMINAL PAIN 4009
43 INFECTION 3882
44 PRODUCT USE IN UNAPPROVED INDICATION 3880
45 CONFUSIONAL STATE 3782
46 CHEST PAIN 3717
47 GAIT DISTURBANCE 3714
48 ALOPECIA 3637
49 URINARY TRACT INFECTION 3500
50 DEPRESSION 3436
51 CHRONIC KIDNEY DISEASE 3427
52 URTICARIA 3410
53 CONTUSION 3407
54 PRODUCT USE ISSUE 3328
55 MUSCLE SPASMS 3327
56 DRUG INTOLERANCE 3314
57 FEELING ABNORMAL 3312
58 SWELLING 3242
59 GASTROINTESTINAL DISORDER 3188
60 COVID-19 3177
61 HYPOAESTHESIA 3132
62 PRODUCT DOSE OMISSION ISSUE 3083
63 HEPATIC ENZYME INCREASED 2912
64 SOMNOLENCE 2885
65 ACUTE KIDNEY INJURY 2859
66 LOWER RESPIRATORY TRACT INFECTION 2826
67 MUSCULOSKELETAL STIFFNESS 2795
68 HYPOTENSION 2791
69 CHILLS 2743
70 INTENTIONAL PRODUCT USE ISSUE 2736
71 MYALGIA 2735
72 STOMATITIS 2660
73 HYPERHIDROSIS 2624
74 HEART RATE INCREASED 2599
75 ARTHROPATHY 2588
76 ERYTHEMA 2585
77 RENAL FAILURE 2578
78 PARAESTHESIA 2564
79 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2563
80 BLISTER 2537
81 ANAEMIA 2450
82 INCORRECT DOSE ADMINISTERED 2403
83 ASTHMA 2332
84 OROPHARYNGEAL PAIN 2294
85 ILL-DEFINED DISORDER 2285
86 OXYGEN SATURATION DECREASED 2267
87 MUSCULAR WEAKNESS 2265
88 TREMOR 2250
89 MIGRAINE 2240
90 DEHYDRATION 2217
91 CHEST DISCOMFORT 2216
92 INFLUENZA 2212
93 IMPAIRED HEALING 2202
94 DYSPEPSIA 2196
95 MEMORY IMPAIRMENT 2179
96 DISCOMFORT 2146
97 ARTHRITIS 2122
98 IRRITABLE BOWEL SYNDROME 2120
99 OEDEMA PERIPHERAL 2047
100 THERAPEUTIC PRODUCT EFFECT DECREASED 2023
101 CONTRAINDICATED PRODUCT ADMINISTERED 2002
102 GASTROOESOPHAGEAL REFLUX DISEASE 2002
103 OSTEOARTHRITIS 1918
104 BLOOD PRESSURE SYSTOLIC INCREASED 1892
105 PALPITATIONS 1868
106 MOBILITY DECREASED 1853
107 BLOOD PRESSURE FLUCTUATION 1851
108 SLEEP DISORDER 1841
109 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1841
110 HAEMOGLOBIN DECREASED 1836
111 INJECTION SITE PAIN 1835
112 SYNOVITIS 1822
113 FOLLICULITIS 1813
114 ILLNESS 1797
115 DRY MOUTH 1775
116 OVERDOSE 1775
117 FLUSHING 1770
118 WOUND 1768
119 MUSCLE INJURY 1748
120 WHITE BLOOD CELL COUNT DECREASED 1744
121 RHINORRHOEA 1723
122 VISION BLURRED 1694
123 GENERAL PHYSICAL HEALTH DETERIORATION 1678
124 TREATMENT FAILURE 1676
125 NEUROPATHY PERIPHERAL 1670
126 SYSTEMIC LUPUS ERYTHEMATOSUS 1661
127 MUSCULOSKELETAL PAIN 1656
128 CEREBROVASCULAR ACCIDENT 1626
129 WHEEZING 1626
130 PSORIASIS 1620
131 HEART RATE DECREASED 1619
132 ABDOMINAL DISTENSION 1585
133 MATERNAL EXPOSURE DURING PREGNANCY 1579
134 PLATELET COUNT DECREASED 1569
135 ATRIAL FIBRILLATION 1561
136 HAND DEFORMITY 1559
137 BRONCHITIS 1551
138 GLOSSODYNIA 1543
139 INFLUENZA LIKE ILLNESS 1540
140 DYSPHAGIA 1534
141 FOETAL EXPOSURE DURING PREGNANCY 1528
142 NECK PAIN 1526
143 SEPSIS 1488
144 NIGHT SWEATS 1479
145 BALANCE DISORDER 1474
146 LOSS OF CONSCIOUSNESS 1471
147 PERICARDITIS 1469
148 NASAL CONGESTION 1456
149 VISUAL IMPAIRMENT 1455
150 UPPER RESPIRATORY TRACT INFECTION 1449
151 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1437
152 PEMPHIGUS 1430
153 HELICOBACTER INFECTION 1407
154 FLUID RETENTION 1403
155 OEDEMA 1384
156 MYOCARDIAL INFARCTION 1376
157 PRODUCTIVE COUGH 1368
158 DRY SKIN 1355
159 HOT FLUSH 1347
160 STRESS 1331
161 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1326
162 PSORIATIC ARTHROPATHY 1322
163 BLOOD CHOLESTEROL INCREASED 1305
164 DUODENAL ULCER PERFORATION 1295
165 EPISTAXIS 1279
166 BLOOD GLUCOSE INCREASED 1272
167 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1271
168 FEELING HOT 1266
169 ADVERSE EVENT 1264
170 TACHYCARDIA 1262
171 INJURY 1259
172 HOSPITALISATION 1234
173 CATARACT 1226
174 LIVER DISORDER 1211
175 GAIT INABILITY 1202
176 THROMBOCYTOPENIA 1198
177 INFLAMMATION 1192
178 THROAT IRRITATION 1189
179 FIBROMYALGIA 1180
180 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1168
181 BURSITIS 1166
182 EAR PAIN 1163
183 DISEASE PROGRESSION 1152
184 NEPHROLITHIASIS 1147
185 AMNESIA 1138
186 INTENTIONAL PRODUCT MISUSE 1136
187 GASTROINTESTINAL HAEMORRHAGE 1135
188 BODY TEMPERATURE INCREASED 1133
189 SYNCOPE 1130
190 CROHN^S DISEASE 1128
191 AUTISM SPECTRUM DISORDER 1127
192 BONE PAIN 1125
193 OSTEOPOROSIS 1125
194 LUNG DISORDER 1117
195 BLOOD PRESSURE DIASTOLIC ABNORMAL 1100
196 ADVERSE DRUG REACTION 1097
197 SEIZURE 1096
198 BLOOD PRESSURE DECREASED 1089
199 HAEMORRHAGE 1061
200 END STAGE RENAL DISEASE 1060
201 THERAPY NON-RESPONDER 1058
202 HALLUCINATION 1057
203 PULMONARY EMBOLISM 1050
204 HERPES ZOSTER 1044
205 DYSGEUSIA 1040
206 THROMBOSIS 1040
207 TYPE 2 DIABETES MELLITUS 1034
208 RESPIRATORY DISORDER 999
209 CARDIAC FAILURE CONGESTIVE 993
210 NEUTROPENIA 985
211 DYSPNOEA EXERTIONAL 977
212 BLOOD PRESSURE SYSTOLIC ABNORMAL 974
213 CARDIAC DISORDER 973
214 BURNING SENSATION 967
215 PLEURAL EFFUSION 964
216 RASH ERYTHEMATOUS 959
217 DRUG DOSE OMISSION 957
218 HAEMATOCHEZIA 953
219 BLOOD CREATININE INCREASED 952
220 ROAD TRAFFIC ACCIDENT 950
221 DYSPHONIA 947
222 LIVER INJURY 936
223 SKIN EXFOLIATION 924
224 CELLULITIS 919
225 PRESCRIBED OVERDOSE 908
226 FLATULENCE 893
227 EMOTIONAL DISTRESS 891
228 EYE PAIN 889
229 THERAPEUTIC RESPONSE UNEXPECTED 880
230 CYSTITIS 878
231 JOINT RANGE OF MOTION DECREASED 878
232 DRY EYE 875
233 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 864
234 RENAL IMPAIRMENT 851
235 DEEP VEIN THROMBOSIS 832
236 DIABETES MELLITUS 832
237 LETHARGY 828
238 MUSCLE SPASTICITY 825
239 SCIATICA 822
240 MALIGNANT NEOPLASM PROGRESSION 819
241 PRODUCT QUALITY ISSUE 816
242 LOWER LIMB FRACTURE 811
243 INJECTION SITE ERYTHEMA 786
244 RHEUMATOID FACTOR POSITIVE 781
245 SWELLING FACE 777
246 RECTAL HAEMORRHAGE 776
247 JOINT STIFFNESS 770
248 RESPIRATORY FAILURE 767
249 RASH PRURITIC 760
250 FEBRILE NEUTROPENIA 755
251 VERTIGO 755
252 IMMUNODEFICIENCY 750
253 BLOOD PRESSURE DIASTOLIC DECREASED 747
254 C-REACTIVE PROTEIN ABNORMAL 742
255 EAR INFECTION 739
256 UNEVALUABLE EVENT 722
257 NIGHTMARE 716
258 PULMONARY FIBROSIS 716
259 SKIN DISCOLOURATION 711
260 SINUS DISORDER 699
261 MULTIPLE SCLEROSIS RELAPSE 698
262 DRUG INTERACTION 693
263 RED BLOOD CELL COUNT DECREASED 689
264 PAIN IN JAW 686
265 DYSURIA 681
266 WHITE BLOOD CELL COUNT INCREASED 679
267 SPEECH DISORDER 675
268 ALANINE AMINOTRANSFERASE INCREASED 671
269 POLLAKIURIA 671
270 DELIRIUM 670
271 RENAL INJURY 668
272 UNDERDOSE 667
273 TINNITUS 661
274 RENAL DISORDER 660
275 LIMB INJURY 655
276 BLOOD POTASSIUM DECREASED 651
277 SUICIDAL IDEATION 651
278 INJECTION SITE BRUISING 641
279 NEURALGIA 638
280 LIMB DISCOMFORT 637
281 THERAPY INTERRUPTED 637
282 C-REACTIVE PROTEIN INCREASED 636
283 NERVOUSNESS 636
284 FOOD ALLERGY 634
285 ANAPHYLACTIC REACTION 625
286 DIVERTICULITIS 622
287 PULMONARY OEDEMA 620
288 RHEUMATIC FEVER 612
289 VIRAL INFECTION 608
290 PRODUCT DOSE OMISSION 604
291 AGITATION 603
292 KNEE ARTHROPLASTY 602
293 SEDATION 601
294 DRUG DEPENDENCE 593
295 DISEASE RECURRENCE 592
296 COLITIS ULCERATIVE 590
297 HYPOXIA 590
298 LIP DRY 590
299 LYMPHADENOPATHY 589
300 COLITIS 588
301 FREQUENT BOWEL MOVEMENTS 586
302 ORAL PAIN 583
303 THERAPEUTIC RESPONSE SHORTENED 579
304 WOUND INFECTION 578
305 RIB FRACTURE 576
306 GASTRIC DISORDER 571
307 MEDICATION ERROR 571
308 TOOTH DISORDER 571
309 IRRITABILITY 568
310 THERAPEUTIC RESPONSE DECREASED 566
311 FEELING COLD 564
312 ACNE 563
313 AUTOIMMUNE DISORDER 563
314 DYSSTASIA 559
315 PANCREATITIS 559
316 SKIN LESION 558
317 LOCALISED INFECTION 557
318 SNEEZING 556
319 DYSARTHRIA 555
320 DEPRESSED MOOD 554
321 HIP ARTHROPLASTY 554
322 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 552
323 INFUSION SITE PAIN 551
324 HIP FRACTURE 550
325 SINUS CONGESTION 548
326 INTESTINAL OBSTRUCTION 540
327 ASPARTATE AMINOTRANSFERASE INCREASED 536
328 DISTURBANCE IN ATTENTION 535
329 HEAD INJURY 535
330 HYPOKALAEMIA 535
331 OBESITY 532
332 TOXICITY TO VARIOUS AGENTS 531
333 SURGERY 530
334 NO ADVERSE EVENT 529
335 SWOLLEN JOINT COUNT INCREASED 526
336 MOVEMENT DISORDER 523
337 BODY TEMPERATURE DECREASED 521
338 CHOLELITHIASIS 518
339 DEVICE ISSUE 518
340 NEPHROGENIC ANAEMIA 516
341 OSTEOPENIA 515
342 RESPIRATORY TRACT CONGESTION 514
343 SKIN DISORDER 514
344 THERAPY CESSATION 514
345 APHASIA 513
346 EATING DISORDER 513
347 TASTE DISORDER 513
348 URINARY INCONTINENCE 512
349 HYPERSOMNIA 511
350 HEART RATE IRREGULAR 508
351 HAEMATOCRIT DECREASED 504
352 MULTIPLE SCLEROSIS 499
353 SEASONAL ALLERGY 498
354 GRIP STRENGTH DECREASED 497
355 EXOSTOSIS 496
356 NEUTROPHIL COUNT DECREASED 496
357 FUNGAL INFECTION 495
358 INJECTION SITE REACTION 493
359 HYPONATRAEMIA 491
360 LABORATORY TEST ABNORMAL 491
361 EYE IRRITATION 490
362 POOR QUALITY SLEEP 490
363 HYPOACUSIS 487
364 EYE SWELLING 486
365 CARDIAC FAILURE 485
366 COGNITIVE DISORDER 483
367 INJECTION SITE SWELLING 477
368 THROAT TIGHTNESS 472
369 STAPHYLOCOCCAL INFECTION 470
370 INJECTION SITE PRURITUS 468
371 PANCYTOPENIA 467
372 BACK DISORDER 465
373 TREATMENT NONCOMPLIANCE 464
374 BLOOD PRESSURE DIASTOLIC INCREASED 463
375 CARDIAC ARREST 461
376 RESPIRATORY TRACT INFECTION 461
377 ANGINA PECTORIS 459
378 PREGNANCY 458
379 INJECTION SITE HAEMORRHAGE 456
380 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 455
381 RED BLOOD CELL SEDIMENTATION RATE INCREASED 453
382 POOR VENOUS ACCESS 449
383 HYPERCHOLESTEROLAEMIA 448
384 PLASMA CELL MYELOMA 448
385 SUICIDE ATTEMPT 448
386 CRYING 446
387 BRADYCARDIA 445
388 CLOSTRIDIUM DIFFICILE INFECTION 444
389 INTERVERTEBRAL DISC PROTRUSION 444
390 RASH MACULAR 444
391 TOOTHACHE 444
392 DEEP VEIN THROMBOSIS POSTOPERATIVE 442
393 TRANSIENT ISCHAEMIC ATTACK 442
394 MENTAL STATUS CHANGES 441
395 HAEMORRHOIDS 440
396 HEPATIC FAILURE 440
397 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 438
398 OCULAR HYPERAEMIA 436
399 PANIC ATTACK 435
400 LYMPHOCYTE COUNT DECREASED 434
401 ACUTE RESPIRATORY FAILURE 432
402 FULL BLOOD COUNT DECREASED 432
403 PRESCRIBED UNDERDOSE 429
404 HEPATIC CIRRHOSIS 426
405 BLOOD URINE PRESENT 424
406 COELIAC DISEASE 424
407 JOINT INJURY 424
408 SKIN ULCER 424
409 MUSCULOSKELETAL CHEST PAIN 421
410 PERIPHERAL VENOUS DISEASE 421
411 MUSCULOSKELETAL DISCOMFORT 420
412 WEIGHT FLUCTUATION 418
413 RETCHING 417
414 LACRIMATION INCREASED 416
415 TEMPERATURE REGULATION DISORDER 415
416 INTERSTITIAL LUNG DISEASE 414
417 KIDNEY INFECTION 413
418 INTENTIONAL OVERDOSE 412
419 MENTAL DISORDER 412
420 ATELECTASIS 409
421 EYE DISORDER 406
422 INTENTIONAL DOSE OMISSION 405
423 LEUKOPENIA 402
424 HYPOPHAGIA 400
425 SLEEP APNOEA SYNDROME 400
426 ECZEMA 399
427 PULMONARY MASS 399
428 DISLOCATION OF VERTEBRA 396
429 HAEMATURIA 396
430 PRODUCT DOSE OMISSION IN ERROR 396
431 GASTRITIS 395
432 BLOOD PRESSURE ABNORMAL 393
433 BREAST CANCER 388
434 HAEMOPTYSIS 387
435 X-RAY ABNORMAL 387
436 NEOPLASM MALIGNANT 386
437 DRUG EFFECT INCOMPLETE 381
438 MIDDLE INSOMNIA 380
439 INFUSION SITE ERYTHEMA 379
440 AGEUSIA 378
441 ARRHYTHMIA 377
442 SARS-COV-2 TEST POSITIVE 377
443 GASTROENTERITIS VIRAL 376
444 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 375
445 PALLOR 375
446 GOUT 373
447 PROCEDURAL PAIN 372
448 PHOTOPHOBIA 371
449 DYSKINESIA 370
450 FOOT DEFORMITY 369
451 DISABILITY 368
452 CYST 366
453 HEPATIC STEATOSIS 366
454 HYPOTHYROIDISM 366
455 TOOTH INFECTION 365
456 FAECES DISCOLOURED 363
457 SKIN BURNING SENSATION 362
458 DRUG EFFECT DECREASED 361
459 FACET JOINT SYNDROME 361
460 FOOT FRACTURE 361
461 PRODUCT SUBSTITUTION ISSUE 357
462 DISORIENTATION 356
463 HEAD DISCOMFORT 355
464 LARYNGITIS 355
465 CORONARY ARTERY DISEASE 354
466 HEMIPARESIS 350
467 EYE PRURITUS 349
468 LIVE BIRTH 349
469 TUBULOINTERSTITIAL NEPHRITIS 348
470 ORAL HERPES 346
471 SEPTIC SHOCK 346
472 WALKING AID USER 345
473 SKIN HAEMORRHAGE 344
474 RESTLESS LEGS SYNDROME 343
475 RESTLESSNESS 341
476 SPUTUM DISCOLOURED 340
477 DEMENTIA 338
478 PERICARDIAL EFFUSION 338
479 PRESYNCOPE 337
480 DIPLOPIA 336
481 LIP SWELLING 336
482 OSTEOMYELITIS 336
483 ABDOMINAL PAIN LOWER 335
484 BONE DISORDER 335
485 ACCIDENTAL EXPOSURE TO PRODUCT 334
486 LIVER FUNCTION TEST INCREASED 334
487 INTERVERTEBRAL DISC DEGENERATION 332
488 BLOOD ALKALINE PHOSPHATASE INCREASED 331
489 GALLBLADDER DISORDER 328
490 MASS 328
491 BRAIN FOG 327
492 HIATUS HERNIA 327
493 SPINAL FRACTURE 326
494 COORDINATION ABNORMAL 324
495 SPINAL OSTEOARTHRITIS 324
496 BLOOD COUNT ABNORMAL 323
497 BLOOD SODIUM DECREASED 321
498 FEMUR FRACTURE 320
499 NEOPLASM PROGRESSION 320
500 RESPIRATORY RATE INCREASED 320
501 URINARY RETENTION 320
502 AGGRESSION 319
503 BREAST CANCER STAGE II 319
504 HERNIA 319
505 BLOOD POTASSIUM INCREASED 317
506 FEEDING DISORDER 316
507 SWOLLEN TONGUE 316
508 HYPOGLYCAEMIA 315
509 JOINT DISLOCATION 315
510 RENAL FAILURE ACUTE 315
511 VAGINAL HAEMORRHAGE 314
512 INFUSION SITE SWELLING 310
513 NERVE COMPRESSION 309
514 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 309
515 BLOOD GLUCOSE DECREASED 308
516 EXTRA DOSE ADMINISTERED 308
517 PULMONARY HYPERTENSION 308
518 GLAUCOMA 305
519 ROTATOR CUFF SYNDROME 305
520 INTERNATIONAL NORMALISED RATIO INCREASED 303
521 MUSCLE TWITCHING 303
522 BLOOD IRON DECREASED 302
523 MUSCULOSKELETAL DISORDER 302
524 ABSCESS 301
525 DRUG-INDUCED LIVER INJURY 301
526 ASCITES 300
527 LIVER FUNCTION TEST ABNORMAL 300
528 TENDERNESS 299
529 NODULE 298
530 BLOOD BILIRUBIN INCREASED 297
531 BODY HEIGHT DECREASED 297
532 BONE EROSION 297
533 ANGER 296
534 PNEUMONITIS 295
535 UPPER LIMB FRACTURE 295
536 BREAST CANCER STAGE III 294
537 DEVICE MALFUNCTION 294
538 MATERNAL EXPOSURE TIMING UNSPECIFIED 294
539 HYPERGLYCAEMIA 292
540 MOUTH ULCERATION 292
541 SENSORY LOSS 292
542 ACCIDENTAL OVERDOSE 291
543 BLINDNESS 291
544 ARTERIAL OCCLUSIVE DISEASE 290
545 FULL BLOOD COUNT ABNORMAL 290
546 LUNG NEOPLASM MALIGNANT 290
547 IMPAIRED GASTRIC EMPTYING 289
548 CEREBRAL HAEMORRHAGE 287
549 DENTAL CARIES 287
550 EXPIRED PRODUCT ADMINISTERED 287
551 DEAFNESS 285
552 CHROMATURIA 284
553 CONVULSION 284
554 LIGAMENT SPRAIN 284
555 MOOD SWINGS 284
556 ANKYLOSING SPONDYLITIS 282
557 MOTOR DYSFUNCTION 282
558 POST PROCEDURAL COMPLICATION 282
559 SCOLIOSIS 282
560 SKIN IRRITATION 281
561 SKIN LACERATION 279
562 SMALL INTESTINAL OBSTRUCTION 279
563 HYPERPARATHYROIDISM SECONDARY 278
564 PRODUCT ADMINISTRATION ERROR 278
565 UNRESPONSIVE TO STIMULI 278
566 IMPAIRED WORK ABILITY 277
567 PNEUMONIA ASPIRATION 277
568 RESPIRATORY DISTRESS 277
569 MUSCLE TIGHTNESS 276
570 PARKINSON^S DISEASE 276
571 ABNORMAL BEHAVIOUR 275
572 BACTERIAL INFECTION 274
573 BLOOD TEST ABNORMAL 272
574 CARPAL TUNNEL SYNDROME 272
575 DRUG WITHDRAWAL SYNDROME 272
576 FEELING JITTERY 272
577 IMPAIRED QUALITY OF LIFE 272
578 SKIN FISSURES 271
579 TENDONITIS 270
580 ANHEDONIA 269
581 HYPOKINESIA 269
582 TOOTH ABSCESS 269
583 UPPER-AIRWAY COUGH SYNDROME 269
584 BONE DENSITY DECREASED 268
585 SKIN CANCER 266
586 DERMATITIS ATOPIC 264
587 GASTRIC ULCER 263
588 LUPUS VULGARIS 263
589 VITAMIN D DEFICIENCY 263
590 MENTAL IMPAIRMENT 262
591 ORAL CANDIDIASIS 262
592 CARDIOMEGALY 261
593 FOETAL DEATH 260
594 HEPATITIS 259
595 HYPOAESTHESIA ORAL 258
596 BACK INJURY 257
597 ACUTE MYOCARDIAL INFARCTION 255
598 CANDIDA INFECTION 255
599 LEUKOCYTOSIS 255
600 SPINAL PAIN 255
601 DRUG ADMINISTRATION ERROR 254
602 HAEMATEMESIS 254
603 HAEMATOMA 253
604 MITRAL VALVE INCOMPETENCE 253
605 UPPER GASTROINTESTINAL HAEMORRHAGE 253
606 LUPUS-LIKE SYNDROME 252
607 APHONIA 251
608 BLOOD MAGNESIUM DECREASED 251
609 ULCER 251
610 HALLUCINATION, VISUAL 250
611 PERIPHERAL COLDNESS 250
612 HYPERKALAEMIA 248
613 INCREASED TENDENCY TO BRUISE 248
614 OBSTRUCTIVE AIRWAYS DISORDER 248
615 INJECTION SITE MASS 247
616 COAGULOPATHY 246
617 SCAR 246
618 GINGIVAL BLEEDING 245
619 HOSPICE CARE 245
620 HYPERLIPIDAEMIA 245
621 WITHDRAWAL SYNDROME 244
622 BLOOD UREA INCREASED 243
623 GANGRENE 243
624 MULTIPLE ALLERGIES 243
625 HEMIPLEGIA 242
626 REBOUND ACID HYPERSECRETION 242
627 THIRST 242
628 PAIN OF SKIN 241
629 JOINT EFFUSION 240
630 MOOD ALTERED 240
631 THYROID DISORDER 240
632 EMOTIONAL DISORDER 239
633 THINKING ABNORMAL 238
634 AFFECT LABILITY 237
635 PERSONALITY DISORDER 237
636 TOOTH FRACTURE 236
637 URINE ABNORMALITY 235
638 INCREASED APPETITE 234
639 MYOSITIS 233
640 NEUTROPHIL COUNT INCREASED 233
641 PHOTOSENSITIVITY REACTION 231
642 COLD SWEAT 230
643 CHOKING 229
644 ACUTE HEPATIC FAILURE 228
645 BASAL CELL CARCINOMA 228
646 ABASIA 227
647 CONCUSSION 227
648 ENCEPHALOPATHY 227
649 DERMATITIS CONTACT 225
650 EYE INFECTION 225
651 MUSCLE ATROPHY 225
652 PARAESTHESIA ORAL 225
653 WRIST FRACTURE 225
654 MALNUTRITION 224
655 RED CELL DISTRIBUTION WIDTH INCREASED 223
656 SECRETION DISCHARGE 223
657 FLANK PAIN 222
658 INJECTION SITE RASH 222
659 PRODUCT STORAGE ERROR 221
660 PRODUCT USE COMPLAINT 221
661 RENAL PAIN 221
662 COMA 220
663 NEPHROPATHY 220
664 APHTHOUS ULCER 219
665 DEPRESSED LEVEL OF CONSCIOUSNESS 219
666 METABOLIC ACIDOSIS 219
667 PSYCHOLOGICAL TRAUMA 219
668 SKIN INFECTION 219
669 ANKLE FRACTURE 218
670 PNEUMOTHORAX 218
671 PREMATURE BABY 218
672 PHARYNGITIS STREPTOCOCCAL 217
673 ABNORMAL DREAMS 216
674 HAIR COLOUR CHANGES 216
675 MICTURITION URGENCY 216
676 PULMONARY CONGESTION 216
677 RASH VESICULAR 216
678 SPLENOMEGALY 215
679 PLATELET COUNT INCREASED 214
680 TOOTH LOSS 213
681 C-REACTIVE PROTEIN 212
682 CONJUNCTIVITIS 211
683 DECREASED ACTIVITY 211
684 FISTULA 211
685 MUSCLE STRAIN 211
686 RASH PAPULAR 210
687 HAIR TEXTURE ABNORMAL 209
688 RETINITIS 209
689 DEVICE DISLOCATION 208
690 EAR DISCOMFORT 208
691 PRURITUS GENERALISED 207
692 BLOOD CALCIUM DECREASED 206
693 BRONCHIECTASIS 205
694 GLOMERULAR FILTRATION RATE DECREASED 205
695 JAUNDICE 205
696 LOCAL SWELLING 205
697 NOCTURIA 205
698 OSTEONECROSIS OF JAW 205
699 PHARYNGITIS 205
700 VITAMIN D DECREASED 205
701 ERUCTATION 204
702 FEAR 204
703 GASTROENTERITIS 204
704 NERVOUS SYSTEM DISORDER 203
705 ORAL DISCOMFORT 202
706 ANAPHYLACTIC SHOCK 201
707 EPIGASTRIC DISCOMFORT 201
708 FINGER DEFORMITY 200
709 DRUG ABUSE 199
710 PULMONARY THROMBOSIS 199
711 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 197
712 PRODUCT PRESCRIBING ERROR 197
713 UVEITIS 197
714 DRY THROAT 196
715 RASH GENERALISED 196
716 ABORTION SPONTANEOUS 195
717 RENAL CYST 195
718 ULCER HAEMORRHAGE 195
719 GENERALISED OEDEMA 194
720 PHARYNGEAL SWELLING 194
721 TRICUSPID VALVE INCOMPETENCE 194
722 VISUAL ACUITY REDUCED 194
723 BEDRIDDEN 193
724 DERMATITIS 193
725 GASTROINTESTINAL PAIN 192
726 NEEDLE ISSUE 192
727 LUNG INFECTION 191
728 INCONTINENCE 190
729 INSURANCE ISSUE 189
730 DEAFNESS NEUROSENSORY 188
731 OCULAR DISCOMFORT 188
732 RENAL TUBULAR NECROSIS 188
733 ARTHRITIS INFECTIVE 187
734 METASTASES TO BONE 187
735 NAIL DISORDER 187
736 SENSORY DISTURBANCE 187
737 SPINAL COMPRESSION FRACTURE 187
738 CARDIAC MURMUR 185
739 VASCULITIS 185
740 BRONCHOSPASM 184
741 ECONOMIC PROBLEM 184
742 INCORRECT PRODUCT ADMINISTRATION DURATION 184
743 INFUSION SITE EXTRAVASATION 184
744 PLEURAL FIBROSIS 184
745 ADJUSTMENT DISORDER 183
746 FACIAL PAIN 183
747 PRODUCT ADMINISTRATION INTERRUPTED 183
748 SINUS TACHYCARDIA 183
749 EMPHYSEMA 182
750 PRODUCT AVAILABILITY ISSUE 182
751 PUSTULAR PSORIASIS 182
752 SCRATCH 182
753 IMMUNE SYSTEM DISORDER 181
754 ACTIVITIES OF DAILY LIVING IMPAIRED 180
755 PROTEINURIA 180
756 ANGIOEDEMA 179
757 BLOOD TRIGLYCERIDES INCREASED 179
758 FRACTURE 179
759 DIZZINESS POSTURAL 178
760 CAROTID ARTERY THROMBOSIS 177
761 COVID-19 PNEUMONIA 177
762 GENERAL SYMPTOM 177
763 SCAB 177
764 BLADDER DISORDER 176
765 DYSLIPIDAEMIA 176
766 INFUSION SITE PRURITUS 176
767 SUBDURAL HAEMATOMA 176
768 PARANOIA 175
769 ATTENTION DEFICIT HYPERACTIVITY DISORDER 174
770 CARDIO-RESPIRATORY ARREST 174
771 DEVICE RELATED INFECTION 174
772 THERAPY PARTIAL RESPONDER 174
773 APPETITE DISORDER 173
774 INJECTION SITE EXTRAVASATION 173
775 IRON DEFICIENCY ANAEMIA 173
776 NEUROLOGIC NEGLECT SYNDROME 173
777 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 173
778 INTERNAL HAEMORRHAGE 172
779 MUCOSAL INFLAMMATION 172
780 DECUBITUS ULCER 171
781 DEVICE DIFFICULT TO USE 171
782 PROSTATE CANCER 171
783 PSYCHOTIC DISORDER 171
784 SPINAL STENOSIS 171
785 TEMPERATURE INTOLERANCE 171
786 FAILURE TO THRIVE 169
787 HEREDITARY ANGIOEDEMA 169
788 INFUSION SITE HAEMORRHAGE 169
789 SPINAL DISORDER 169
790 SPINAL OPERATION 169
791 ANAL INCONTINENCE 168
792 NERVE INJURY 168
793 GINGIVAL PAIN 167
794 GLYCOSYLATED HAEMOGLOBIN INCREASED 167
795 FLUID OVERLOAD 166
796 ATRIAL SEPTAL DEFECT 165
797 BREAST PAIN 165
798 CLOSTRIDIUM DIFFICILE COLITIS 165
799 DELUSION 165
800 MADAROSIS 164
801 UTERINE LEIOMYOMA 164
802 CORONARY ARTERY OCCLUSION 163
803 EAR PRURITUS 163
804 DEFORMITY 161
805 HYPOMAGNESAEMIA 161
806 POST PROCEDURAL INFECTION 161
807 DEVICE LEAKAGE 160
808 DIABETES MELLITUS INADEQUATE CONTROL 160
809 EPILEPSY 160
810 LOWER GASTROINTESTINAL HAEMORRHAGE 160
811 TENDON RUPTURE 160
812 TOOTH EXTRACTION 160
813 TRANSAMINASES INCREASED 160
814 EOSINOPHIL COUNT INCREASED 159
815 GROIN PAIN 159
816 METASTASES TO LIVER 159
817 ORTHOSTATIC HYPOTENSION 159
818 ADRENAL INSUFFICIENCY 158
819 BRAIN OEDEMA 158
820 IMMUNOSUPPRESSION 158
821 INJECTION SITE URTICARIA 158
822 OROPHARYNGEAL DISCOMFORT 158
823 QUALITY OF LIFE DECREASED 158
824 CHOLECYSTITIS 157
825 RALES 157
826 BLOOD CREATINE PHOSPHOKINASE INCREASED 156
827 PROTEIN URINE PRESENT 155
828 BACTERAEMIA 154
829 DRUG EFFECT LESS THAN EXPECTED 154
830 EOSINOPHILIA 153
831 CYANOSIS 152
832 FRUSTRATION TOLERANCE DECREASED 152
833 HAND FRACTURE 152
834 LUNG INFILTRATION 152
835 SINUS HEADACHE 152
836 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 152
837 BLOOD LACTATE DEHYDROGENASE INCREASED 151
838 DIVERTICULUM 151
839 PSYCHOMOTOR HYPERACTIVITY 151
840 PRODUCT PHYSICAL ISSUE 150
841 SHOCK 150
842 STEVENS-JOHNSON SYNDROME 150
843 TACHYPNOEA 150
844 CARDIOMYOPATHY 149
845 HUNGER 149
846 MULTIPLE FRACTURES 149
847 PLEURAL THICKENING 149
848 DECREASED IMMUNE RESPONSIVENESS 148
849 PRODUCT PRESCRIBING ISSUE 148
850 TROPONIN INCREASED 148
851 ECCHYMOSIS 147
852 LACERATION 147
853 POLYP 147
854 UROSEPSIS 147
855 BLINDNESS UNILATERAL 145
856 HYPERCALCAEMIA 145
857 MENORRHAGIA 145
858 OVARIAN CYST 145
859 PROSTATIC SPECIFIC ANTIGEN INCREASED 145
860 INCORRECT DRUG ADMINISTRATION DURATION 144
861 MACULAR DEGENERATION 144
862 TRANSFUSION 144
863 HAEMOGLOBIN INCREASED 143
864 INITIAL INSOMNIA 143
865 SKIN REACTION 143
866 BLOOD ALBUMIN DECREASED 142
867 EJECTION FRACTION DECREASED 142
868 ELECTROLYTE IMBALANCE 142
869 INTESTINAL PERFORATION 142
870 BLOOD PRESSURE SYSTOLIC DECREASED 141
871 BOWEL MOVEMENT IRREGULARITY 141
872 RHINITIS 141
873 CENTRAL NERVOUS SYSTEM LESION 140
874 PELVIC FRACTURE 140
875 PELVIC PAIN 140
876 PRESBYACUSIS 140
877 ASPIRATION 139
878 HEPATOTOXICITY 139
879 SUPRAVENTRICULAR TACHYCARDIA 139
880 ACCIDENT 138
881 FEELING OF BODY TEMPERATURE CHANGE 138
882 HEPATIC FUNCTION ABNORMAL 138
883 LYMPHOEDEMA 138
884 ONYCHOCLASIS 138
885 RESPIRATORY SYNCYTIAL VIRUS INFECTION 138
886 DEVICE OCCLUSION 137
887 ELECTROCARDIOGRAM QT PROLONGED 137
888 EYE HAEMORRHAGE 137
889 MALIGNANT MELANOMA 137
890 MATERNAL EXPOSURE BEFORE PREGNANCY 137
891 SJOGREN^S SYNDROME 137
892 SKIN ATROPHY 137
893 SLUGGISHNESS 137
894 HAIR DISORDER 136
895 CYTOKINE RELEASE SYNDROME 135
896 OSTEONECROSIS 135
897 BONE LOSS 134
898 ORAL DISORDER 134
899 ARTHROPOD BITE 133
900 COLON CANCER 133
901 DECREASED INTEREST 133
902 DRUG LEVEL DECREASED 133
903 WRONG TECHNIQUE IN DRUG USAGE PROCESS 133
904 ATRIAL FLUTTER 132
905 BLOOD MAGNESIUM INCREASED 132
906 DEFAECATION URGENCY 132
907 DRUG EXPOSURE DURING PREGNANCY 132
908 MELAENA 132
909 PHARYNGEAL OEDEMA 132
910 PRODUCT ADHESION ISSUE 132
911 CHOLECYSTECTOMY 131
912 LARGE INTESTINE POLYP 131
913 FAECES SOFT 130
914 PARALYSIS 130
915 PROCTALGIA 130
916 SYNOVIAL CYST 130
917 FURUNCLE 129
918 HYPERKERATOSIS 129
919 ORAL MUCOSAL BLISTERING 129
920 SKIN ABRASION 129
921 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 128
922 BRONCHIAL SECRETION RETENTION 128
923 ESSENTIAL HYPERTENSION 128
924 GASTROINTESTINAL INFECTION 128
925 IRON DEFICIENCY 128
926 MENISCUS INJURY 128
927 OESOPHAGITIS 128
928 ARTERIOSCLEROSIS 127
929 BLEPHAROSPASM 127
930 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 127
931 NEOPLASM 127
932 HEPATOMEGALY 126
933 LYMPHOMA 126
934 URINE OUTPUT DECREASED 126
935 BRAIN INJURY 125
936 COMPLICATION ASSOCIATED WITH DEVICE 125
937 EYE DISCHARGE 125
938 PETECHIAE 125
939 PULMONARY ARTERIAL HYPERTENSION 125
940 SKIN WARM 125
941 EYE INFLAMMATION 124
942 PNEUMONIA BACTERIAL 124
943 ILEUS 123
944 CONGENITAL ANOMALY 122
945 INJECTION SITE WARMTH 122
946 METASTASES TO LUNG 122
947 ABNORMAL FAECES 120
948 ADVERSE REACTION 120
949 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 120
950 VENTRICULAR EXTRASYSTOLES 120
951 ANAL FISSURE 119
952 BLOOD GLUCOSE ABNORMAL 119
953 ERECTILE DYSFUNCTION 119
954 POSTOPERATIVE WOUND INFECTION 119
955 CEREBRAL DISORDER 118
956 HYPERAESTHESIA 118
957 INFUSION SITE BRUISING 118
958 OSTEOSCLEROSIS 118
959 MYELODYSPLASTIC SYNDROME 117
960 PULMONARY FUNCTION TEST DECREASED 117
961 RASH MACULO-PAPULAR 117
962 VIRAL UPPER RESPIRATORY TRACT INFECTION 117
963 VITREOUS FLOATERS 117
964 INFUSION SITE REACTION 116
965 POST-TRAUMATIC STRESS DISORDER 116
966 DIABETIC KETOACIDOSIS 115
967 INCORRECT DRUG ADMINISTRATION RATE 115
968 MUSCLE DISORDER 115
969 NASAL DISCOMFORT 115
970 PRODUCT DISTRIBUTION ISSUE 115
971 SENSATION OF FOREIGN BODY 115
972 FACIAL PARALYSIS 114
973 FIBROSIS 114
974 HYDRONEPHROSIS 114
975 MYASTHENIA GRAVIS 114
976 OBSTRUCTION 114
977 ODYNOPHAGIA 114
978 PORPHYRIA ACUTE 114
979 URINE ODOUR ABNORMAL 114
980 WHITE BLOOD CELLS URINE POSITIVE 114
981 COMPLETED SUICIDE 113
982 GAMMA-GLUTAMYLTRANSFERASE INCREASED 113
983 HAEMORRHAGE INTRACRANIAL 113
984 INFLAMMATORY BOWEL DISEASE 113
985 OVERWEIGHT 113
986 RHABDOMYOLYSIS 113
987 VARICOSE VEIN 113
988 DRUG LEVEL BELOW THERAPEUTIC 112
989 PAROSMIA 112
990 SQUAMOUS CELL CARCINOMA 112
991 UMBILICAL HERNIA 112
992 VENTRICULAR TACHYCARDIA 112
993 CYTOPENIA 111
994 DIARRHOEA HAEMORRHAGIC 111
995 THERAPEUTIC PRODUCT EFFECT VARIABLE 111
996 AORTIC ANEURYSM 110
997 BREATH SOUNDS ABNORMAL 110
998 EAR DISORDER 110
999 HYPOCALCAEMIA 110